Studies utilizing gene knockout and pharmacologic inhibition have demonstrated that the Rheb/mTORC1/S6K/c-myc pathway plays a crucial role in T-ALL tumor growth, promoting tumor cell survival and proliferation (26, 27). This evidence concerns the gene RPS6KB1 and acute lymphoblastic leukemia.